From Casetext: Smarter Legal Research

Walker v. America

UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF CALIFORNIA
May 17, 2021
Case No.: 20-cv-2311-DMS-BGS (S.D. Cal. May. 17, 2021)

Opinion

Case No.: 20-cv-2311-DMS-BGS

05-17-2021

GEORGE WALKER, Plaintiff, v. TAKEDA PHARMACEUTICALS AMERICA, INC. et al., Defendants.


ORDER GRANTING LEAVE TO AMEND COMPLAINT

On April 12, 2021, Plaintiff George Walker filed a motion to amend his complaint pursuant to Fed. R. Civ. P. 15(a)(2). (ECF No. 4.) Defendants did not file a response in opposition to the motion.

Rule 15(a)(2) provides that "a party may amend its pleading only with the opposing party's written consent or the court's leave." However, the rule further provides that "court[s] should freely give leave when justice so requires." Fed. R. Civ. P. 15(a)(2). The decision to grant leave to amend is one that rests in the discretion of the trial court. See Int'l Ass'n of Machinists & Aerospace Workers v. Republic Airlines, 761 F.2d 1386, 1390 (9th Cir. 1985). The policy in favor of granting leave to amend "is to be applied with extreme liberality." Eminence Capital, LLC v. Aspeon, Inc., 316 F.3d 1048, 1051 (9th Cir. 2003) (quotation omitted). This liberality dictates that the nonmoving party bears the burden of demonstrating why leave to amend should not be granted. Grant v. Hill, 11- cv-3015-JAH, 2021 WL 1378813, at *1 (S.D. Cal. Jan. 21, 2021) (citing Genentech, Inc. v. Abbott Laboratories, 127 F.R.D. 529, 530-31 (N.D. Cal. 1989)).

In determining whether to allow an amendment under Rule 15(a)(2), courts generally consider five factors: (1) "undue delay," (2) "bad faith or dilatory motive on the part of the movant," (3) "repeated failure to cure deficiencies by amendments previously allowed," (4) "undue prejudice to the opposing party by virtue of allowance of the amendment," and (5) "futility of amendment." Foman v. Davis, 371 U.S. 178, 182 (1962); see also Smith v. Pac. Prop. Dev. Co., 358 F.3d 1097, 1101 (9th Cir. 2004) (citing the Foman factors).

Here, Plaintiff filed his motion to amend less than four months after filing his initial complaint. (See ECF Nos. 1, 4.) Further, the proposed amendment to the Complaint would be Plaintiff's first. Finally, Defendants failed to put forward any argument that Plaintiff's amendment would be futile, prejudicial, or otherwise in bad faith. Therefore, Plaintiff's motion for leave to amend is granted.

This motion is currently scheduled for a hearing on May 21, 2021. That hearing is vacated as moot in light of this order. --------

IT IS SO ORDERED. Dated: May 17, 2021

/s/_________

Hon. Dana M. Sabraw

Unites States Chief District Judge


Summaries of

Walker v. America

UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF CALIFORNIA
May 17, 2021
Case No.: 20-cv-2311-DMS-BGS (S.D. Cal. May. 17, 2021)
Case details for

Walker v. America

Case Details

Full title:GEORGE WALKER, Plaintiff, v. TAKEDA PHARMACEUTICALS AMERICA, INC. et al.…

Court:UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF CALIFORNIA

Date published: May 17, 2021

Citations

Case No.: 20-cv-2311-DMS-BGS (S.D. Cal. May. 17, 2021)